Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17684468 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Chromium Picolinate (600 mcg Cr) + biotin (2 mg)

Indicates status has not been verified in more than two years